News - 03 Feb `20Emerging drugs for the treatment of vitiligo

New

Our co-authored paper titled Emerging drugs for the treatment of vitiligo has been published in the journal Expert Opinion on Emerging Drugs.

This study comprehensively summarizes the current concepts in the pathogenesis of vitiligo with special focus on the cytokine and signaling pathways, which are the targets for newer drugs. JAK kinase signaling pathways and the cytokines involved are the focus of vitiligo treatment in current research, followed by antioxidant and repigmenting mechanisms, basic fibroblast growth factors, afamelanotide and targeted immunotherapy.

For more information about emerging treatments for vitiligo, check out Drug Pipelines or Trials Hub sections of our website.

We also recommend reading our exclusive Vitiligo Drug Pipeline Analysis and Market Insights

 

      FAQOther Questions

      • Shall I take vitamin D for my vitiligo?

        In Brief Vitamin D plays a central role in the prevention of different inflammatory and chronic diseases. Consuming 1,000–4,000 IU (25–100 mcg) of vitamin D3 daily should be id...

      • Pyrostegia venusta as a folk medicine for vitiligo?

        Pyrostegia venusta is a neotropical evergreen vine widely spread in Brazil throughout fields, at the coast, edge of the woods and along roadsides (see photo below). Popularly kn...

      • What tests should be done?

        A well-trained dermatologist should be able to diagnose vitiligo and distinguish it from contact leukoderma or more than twenty other conditions with similar skin appearance bas...